Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1984 Nov-Dec;24(11-12):528-31.
doi: 10.1002/j.1552-4604.1984.tb02763.x.

The clearance of cyclosporine by hemodialysis

The clearance of cyclosporine by hemodialysis

R Venkataramanan et al. J Clin Pharmacol. 1984 Nov-Dec.

Abstract

The pharmacokinetics of cyclosporine were studied in five liver transplant patients when they were on and off hemodialysis. There was no significant difference in the blood clearance of cyclosporine between these two periods. Less than 1 per cent of the dose of cyclosporine was recovered in the dialysate. The mean dialysis clearance was less than 1 ml/min. This represents less than 1 per cent of the total blood clearance of cyclosporine. Dosage alterations of cyclosporine during or after hemodialysis do not appear to be necessary.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Borel JF, Feurer C, Gubler HU, Stahelin H. Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions. 1976;6:468–475. - PubMed
    1. Calne RY, Thiru S, Memaster P, Craddock GN, White DJG, Evans DB, Dunn DC, et al. Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet. 1978;2:1323–1327. - PubMed
    1. Starzl TE, Klintmalm GB, Porter KA, Iwatsuki S, Schroter GP. Liver transplantation with use of cyclosporin A and prednisone. N Engl J Med. 1981;305:266–269. - PMC - PubMed
    1. Reitz BA, Bieber CP, Rawey AA, Pennock JL, Jamieson SW, Oyer PE, Stinson EB. Orthotopic heart and combined heart and lung transplantation with cyclosporin A immune suppression. Transplant Proc. 1981;13:393–396. - PubMed
    1. Powels RL, Clink H, Cloane J, Barrett AJ, Kay HEM, McElwain TJ. Cyclosporin A for the treatment of graft-versus-host disease in man. Lancet. 1978;2:1327–1331. - PubMed

Publication types